A phosphopeptide order is not fully defined by adding “phosphorylated” to the sequence. The supplier needs the modified residue, positional numbering, terminal groups, salt form and intended comparison materials. During a custom phosphorylated peptide synthesis service review, I also ask how the laboratory distinguishes the target from unphosphorylated, partially phosphorylated and positional-isomer impurities.
Specify every phosphorylation site
Mark phosphoserine, phosphothreonine or phosphotyrosine directly in the controlled sequence. For multiply phosphorylated targets, list every site rather than relying on a total phosphate count. A mono-phosphorylated product at the wrong residue can have the expected intact mass.
Include the protein numbering system only as supporting information. The manufacturing specification should use unambiguous peptide residue positions because isoforms and initiator-methionine conventions can shift biological numbering.
Decide which control peptides are required
Kinase, phosphatase, binding and antibody studies often need a matched non-phosphorylated peptide. Some projects also require a phosphomimetic sequence, although aspartate or glutamate does not reproduce every structural or charge property of phosphate. Order controls from the same documented sequence and terminal configuration.
For quantitative work, consider whether a stable-isotope-labeled phosphopeptide is needed. The heavy label, phosphate site and enrichment must be specified independently.
Synthesis chemistry changes with phosphate load
Protected phospho-amino-acid building blocks can be incorporated during solid-phase peptide synthesis, but coupling efficiency and deprotection behavior depend on residue, neighboring sequence and protection strategy. Multiple phosphates increase charge and can reduce retention on conventional reversed-phase purification.
Ask the supplier to inspect the crude profile for deletion products and incomplete phosphorylation. A clean final HPLC trace does not show whether purification removed most of the batch or whether the route is robust enough for repeat supply.
Control dephosphorylation and rearrangement
Harsh cleavage, prolonged basic exposure and some sample-preparation conditions can reduce phosphate recovery. The manufacturing record should define cleavage, neutralization, purification and drying conditions. During analytical handling, use clean containers and suitable solvents; contaminating phosphatases are a practical risk in biological workflows, though they are not normally part of chemical manufacture.
Storage claims should fit the exact product. Hygroscopic salts, repeated freeze-thaw and poorly controlled solution pH can change recovery even if the covalent phosphate remains intact.
LC-MS must support site identity
Intact LC-MS can confirm the expected mass increment, but it cannot always localize a phosphate. Tandem MS should provide fragments on both sides of the modified residue where site certainty matters. Neutral loss can dominate some fragmentation spectra, so the laboratory may need optimized collision conditions or an alternative fragmentation mode.
Request annotated spectra and a coverage map. If adjacent serine or threonine residues prevent confident localization, the report should say so rather than assign a site from the order form.
Chromatography needs a suitable method
Phosphorylation changes charge and retention. The parent and phosphopeptide may separate well under one gradient and overlap under another. Review the stationary phase, mobile phase, gradient, wavelength, injection amount and integration table. For multi-phosphorylated material, ion-pairing conditions can strongly influence peak shape.
HPLC area purity is not net content. Counterions, water and residual salts can represent substantial gross weight. Request peptide-content data when the study depends on molar concentration.
- Controlled sequence with residue-level phosphate sites.
- Matched unmodified controls and terminal configuration.
- Final and crude HPLC/LC-MS evidence.
- MS/MS localization where the application requires it.
- Content basis, counterion, water, fill and storage.
What purity is appropriate for a phosphopeptide? It depends on whether the material is used for screening, antibody work or quantitative calibration. A higher area percentage cannot compensate for uncertain site localization. Send the assay, required controls, scale and acceptance criteria with the RFQ so the supplier can design the route and QC package around the actual experiment.